Personalizing therapy in CRS: From Cytokins to clinical choices

.ical

09-09, 14:00–14:30 (Europe/Istanbul), Rhinology 1 (ICC - B2 level BEYAZIT)

Sietze Reitsma

This speaker also appears in:

• Real world evidence in biological therapy for CRSwNP: Current status in 2026
• Should we reduce dosing frequency in Biologic responders: Pros and Cons?
• What's New in CRS? Updates from Recent Clinical Trials and Consensus Statements
• CSR Pathophysiology Update 2026

Stefania Gallo

This speaker also appears in:

• Real world evidence in biological therapy for CRSwNP: Current status in 2026